Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.14
+0.16 (3.21%)
Dec 20, 2024, 4:00 PM EST - Market closed
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $285.75 million as of December 20, 2024. Its market cap has increased by 37.57% in one year.
Market Cap
285.75M
Enterprise Value
57.42M
1-Year Change
37.57%
Ranking
Category
Stock Price
$5.14
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $285.75M, a decrease of -49.46%. That is a compound annual growth rate of -15.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 285.75M | 4.94% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | 721.42M | 27.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cerus | 293.43M |
| 4D Molecular Therapeutics | 291.70M |
| Aclaris Therapeutics | 291.00M |
| Aldeyra Therapeutics | 290.60M |
| Canopy Growth | 286.25M |
| Candel Therapeutics | 284.16M |
| Procaps Group | 283.19M |
| aTyr Pharma | 281.21M |